Solidarity is not built on pity. True solidarity shuns charity in favour of justice. Today that includes accepting that USAID ...
The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...
Sobi announces a new research collaboration on the development of Gamifant in sepsis, which is to be presented at the ISICEM congress: Stockholm Thursday, March 20, 2025, 12:00 Hr ...
An exclusive interview with Sajda Pathan, the young girl who worked as a child laborer in India's New Delhi before featuring ...
The promotional poster for the upcoming television series ... of crime as a result of the isolation that came with being an orphan at an early age. Over the course of his life, he has developed ...
Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced that the ...
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have each granted orphan drug designation to ulviprubart for the treatment of IBM. IBM is an autoimmune disease in ...
Posters will be showcased during the Poster ... Sevasemten has achieved notable regulatory milestones by securing FDA Orphan Drug Designation for the treatment of Becker and Duchenne, Rare ...
In 2025, Cellectis will continue to focus its efforts and expenses on advancing its core clinical trials BALLI-01 and NATHALI ...
"A big wedding party with all the people we love? I want the same thing... with you." Wayfarer Studios has unveiled an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results